Jason D Legassie

Jason D Legassie has a diverse work experience in the field of formulation development. Jason D is currently working at Sage Therapeutics as the Director of Formulation Development, a position they have held since September 2021. Prior to this, they served as the Associate Director of Formulation Development at Sage Therapeutics from November 2019 until September 2021.

Before joining Sage Therapeutics, Jason worked as the Director of Formulation at Axcella from July 2018 to November 2019. Jason D also held the position of Director of Formulation Development at Sancilio & Company from January 2016 to July 2018. Before that, they were the R&D Formulation Manager at Sancilio & Company from April 2014 to December 2015.

Jason's earlier work experience includes serving as an Adjunct Professor at Florida Atlantic University from 2015 to 2018, where they taught courses on drug development and regulation, and drug discovery and formulation. Jason D was also a Senior R&D Scientist at Pfizer from 2011 to 2014, and a Formulation Product Development Manager at Chattem, A Sanofi Company from 2007 to 2011.

Jason's career in the field of formulation development began as a Pharmaceutical Graduate Research Assistant at the University of North Carolina at Chapel Hill, a position they held from 2002 to 2007.

Jason D. Legassie has a Ph.D. in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill. Jason D also holds a Bachelor of Science degree in Chemistry and Biology from the University of Central Florida.